Concepedia

Publication | Open Access

Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study

DOIFull Paper Access

39

Citations

16

References

2021

Year

Marcus Maurer, Ana M. Giménez‐Arnau, Jonathan A. Bernstein, Chia‐Yu Chu, I V Danilycheva, Michihiro Hide, Martin Metz, Sinisa Savic, Karl Sitz, Weily Soong,
Allergy

Abstract

ClinicalTrials.gov Identifier: NCT02477332 and NCT02649218.

References

YearCitations

Page 1